Article

Transplantation of cardiotrophin-1-expressing myoblasts to the left ventricular wall alleviates the transition from compensatory hypertrophy to congestive heart failure in Dahl salt-sensitive hypertensive rats

Kobe University, Kōbe, Hyōgo, Japan
Journal of the American College of Cardiology (Impact Factor: 16.5). 07/2004; 43(12):2337-47. DOI: 10.1016/j.jacc.2004.02.048
Source: PubMed

ABSTRACT

We investigated whether autologous transplantation of skeletal myoblasts (MB) transferred with cardiotrophin-1 (CT-1) gene could retard the transition to heart failure (HF) in Dahl salt-sensitive (DS) hypertensive rats.
Although MB is a therapeutic candidate for chronic HF, little is known about the efficiency of this strategy when applied in nonischemic HF. Cardiotrophin-1 has potent hypertrophic and survival effects on cardiac myocytes. We hypothesized that transplantation of CT-1-expressing myoblasts could provide cardioprotective effects against ventricular remodeling in DS hypertensive rats.
The DS rats were fed a high salt diet for 6 weeks and developed left ventricular (LV) hypertrophy at 11 weeks. At this stage, animals underwent MB to the myocardium with skeletal myoblasts transferred with CT-1 gene using retrovirus (transplantation of CT-1-expressing myoblasts [MB + CT], n = 31) or myoblasts alone (MB, n = 31). The sham group rats were injected with phosphate-buffered saline (n = 24).
At 17 weeks, MB and MB + CT groups showed a significant alleviation of LV dilation and contractile dysfunction compared with the sham group. The degree of alleviation was significantly greater in the MB + CT group than the MB group (LV end-diastolic dimension: sham 7.06 +/- 0.14 mm, MB 6.51 +/- 0.16 mm, MB + CT 6.24 +/- 0.07 mm; fractional shortening: sham 32.1 +/- 1.4%, MB 38.5 +/- 1.5%, MB + CT 43.2 +/- 0.8%). Histological examination revealed that the myocyte size was 20% larger in the MB + CT group at 17 weeks than in the age-matched sham group. Upregulation of renin-angiotensin and endothelin systems during the transition to HF was attenuated by myoblast transplantation, and this effect was enhanced in the MB + CT group.
Transplantation of skeletal myoblasts combined with CT-1-gene transfer could be a useful therapeutic strategy for HF.

Download full-text

Full-text

Available from: Tomomi Ueyama, Mar 13, 2014
  • Source
    • "Previous studies have shown that delivery of ex vivo expanded bone marrow and peripheral blood-derived progenitor cell populations has the potential to stimulate and promote neovascularization within ischemic tissues both in animal models and clinical trials (Kawamoto et al. , 2001; Kocher et al. , 2001b; Orlic et al. , 2001; Ruel et al. , 2005; Suuronen et al. , 2006a, 2006b, 2007; Schinkel et al. , 2010). In the animal models, delivery of these progenitor cells promotes reperfusion of the ischemic tissue and leads to improved cardiac output (Kocher et al. , 2001a; Yeh et al. , 2003; Toh et al. , 2004). These fi ndings are recapitulated in clinical trials where cardiac improvements have been reported at 1 year (Schachinger et al. , 2004; Zhang et al. , 2009; Fadini et al. , 2010; Jiang et al. , 2010) and at 5 years (Meyer et al. , 2009; Schaefer et al. , 2010; Leistner et al. , 2011) after cell treatment delivery. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Endothelial progenitor cell (EPC) therapy has emerged as a promising treatment in cardiac regeneration. EPCs are capable of promoting neovascularization within ischemic tissues, but past studies have had limited success in vivo due to the poor retention and survival of cells within the injured area. In addition, the environment into which the cells are being transplanted may negatively influence the therapeutic potential of the transplanted cells. To overcome these hurdles, various biomaterials are being engineered to include a variety of proteins and peptides to increase cellular adhesion, survival and angiogenesis. This chapter will describe how such strategies are expected to enhance EPCs, and their ability to promote cardiac repair and regeneration.
    Full-text · Chapter · Dec 2014
  • Source
    • "SMs can be easily obtained from patients and cultured in vitro where they maintain native morphological and functional characteristics [97]. These cells can engraft as shown in clinical and experimental studies of MI with improvement of systolic and diastolic cardiac function [98] [99] [100] [101] [102]. However, SMs fail to electromechanically couple with resident cardiomyocytes when transplanted into ischemic myocardium [103] [104]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The general introduction in Chapter 1 of this thesis provides an overview of the emerging field of regenerative medicine, and its different areas of technology. Contemporary approaches to heart valve repair and replacement by mechanical and biological prosthesis, as well as their limitations are discussed. Furthermore, the novel approach of (stem)cell-based therapy in ischemic heart disease and a variety of potential cell types are described. In Part I of the thesis different methods to produce completely acellular porcine and rat aortic valve scaffolds for the purpose of creating a biological substitute that can restore, maintain, or improve normal function. In addition, the in vivo behavior of these valves was studied in a rat model. Subsequently, Part II of the thesis studied the in vivo behavior and functional improvement after transplantation of different human cell types in an animal model of acute myocardial infarction. Furthermore, the feasibility of combining cell therapy with gene-therapy was studied in this same model. Finally, in Part III different methods for cardiac phenotyping in mice were assessed and compared.
    Preview · Article ·
  • [Show abstract] [Hide abstract]
    ABSTRACT: Silica-based hybrid mesostructured materials (MCM-41 type) containing surfactant- embedded Methylene Blue have been prepared and characterized by several techniques, including UV-Vis spectroscopy and cyclic voltammetry, and compared to other systems containing the same dye molecule. The micellar phase of the hybrid material was found to be permeable to protons, which may be of interest for potential applications in chemical and biological sensing devices.
    No preview · Article · Dec 2003 · Studies in surface science and catalysis
Show more